
Structural biologists have successfully resolved the highest-resolution images to date of a crucial single-strand DNA annealing mechanism, exposing a previously undocumented molecular vulnerability that allows malignant cells harboring BRCA mutations to evade destruction and continue replicating. Published on April 27, 2026, as a designated Breakthrough Article in the peer-reviewed journal Nucleic Acids Research, the findings provide a detailed structural blueprint for developing targeted oncological therapies that inhibit the RAD52 protein family and induce synthetic lethality in aggressive breast and ovarian cancers.
Because human RAD52 operates with a rapid mechanistic speed and structural complexity that consistently defies standard observational techniques, researchers bypassed these inherent limitations by analyzing Mgm101, an ancestral yeast mitochondrial protein that executes an identical genetic repair function. By observing this evolutionary predecessor, the scientific team captured the elusive single-strand annealing process that compensatory proteins rely upon to stitch broken genetic strands back together when normal BRCA tumor-suppression genes are disabled by inherited mutations.
The rigorous investigation, detailed in a report by Newswise, utilized a combination of cryogenic electron microscopy conducted at The Ohio State University College of Medicine alongside native mass spectrometry and mass photometry spearheaded by the Georgia Institute of Technology. These complementary, state-of-the-art imaging modalities allowed researchers to freeze the delicate molecular structures in a thin layer of amorphous ice while simultaneously using targeted light to measure the exact masses of the protein-DNA complexes floating freely in solution.
Analytical results from the mass photometry techniques revealed that the ancestral Mgm101 protein assembles from a single monomer unit into a massive configuration, forming a functional ring composed of nineteen identical copies. Vicki Wysocki, professor emerita at Ohio State and chair of the School of Chemistry and Biochemistry at the Georgia Institute of Technology, explained how this architecture serves as a physical template for genetic reconstruction.
This ring is sitting there as a template so that the first strand of the DNA can come down, and then the second strand comes on and starts being annealed to the first strand.
The high-resolution cryo-EM data successfully captured the entire reaction pathway, documenting the initial substrate phase with a single attached DNA strand, a newly observed duplex intermediate stage, and the final B-form product where the repaired double helix is released. During this intermediate phase, researchers observed that the protein binds the initial DNA strand exclusively by its sugar-phosphate backbone, leaving the nucleotide bases completely unwound, separated, and exposed upward so they can be rapidly searched and matched to their complementary genetic sequence.
Capturing the duplex intermediate conformation resolves a long-standing debate within the field of molecular biology regarding whether this specific genetic repair mechanism requires one or two participating protein rings to function effectively. The definitive structural evidence confirms that the single-strand annealing process is managed entirely by a single molecular complex, establishing it as a conserved cis mechanism that operates efficiently and independently of any secondary ring structures.
Understanding the precise physical conformation of these nucleotide bases during the intermediate repair stage offers pharmaceutical developers a highly specific geometric target for designing novel small-molecule inhibitors. Because tumors with mutated BRCA1 and BRCA2 genes rely entirely on this backup RAD52 pathway to survive routine cellular damage, successfully blocking the protein’s ability to bind and search the exposed DNA strands would selectively eradicate the malignant cells without harming surrounding healthy tissue.
Charles Bell, professor of biological chemistry and pharmacology at The Ohio State University College of Medicine and senior author of the study, emphasized that mapping these transitional states bridges a critical gap in contemporary oncology research.
Here, we have more of the states along the full pathway from substrate, to intermediate and product. And the duplex intermediate is a conformation that’s never been seen before.
Bell noted that while the complete mechanism remains a proposed model, acquiring these detailed snapshots of single-strand annealing directly focuses ongoing strategies for precision drug development.
Moving forward, the collaborative research team intends to apply these validated observational techniques directly to human RAD52, prioritizing the isolation of its duplex intermediate phase to confirm structural parallels with the established yeast model. By expanding the application of native mass spectrometry to analyze precisely how human DNA binds to the repair protein, investigators hope to map the exact binding affinities that dictate the survival and proliferation of treatment-resistant carcinomas.
Supported by funding from the U.S. National Science Foundation and the National Institutes of Health, this structural biology breakthrough establishes a new methodological standard for investigating transient cellular repair mechanisms in real time. As researchers transition from ancestral proxies to human targets, the detailed imaging of the ring complex provides the essential molecular coordinates needed to accelerate the discovery of next-generation synthetic lethality drugs for BRCA-mutated cancers.